|
Genentech, Inc.
|
| Link ID |
246362 |
| Title |
Genentech, Inc. |
| Url |
http://www.gene.com/ |
| Description |
Genetic engineering techniques in the discovery, development, production, and marketing of human therapeutics. Includes research history, product pipline, global corporate and career information, from South San Francisco, California. |
| Category |
Biotechnology and Pharmaceuticals > Pharmaceuticals > Biopharmaceuticals > Research and Development |
| Keywords |
|
| Date |
Jul 19, 2006 |
| Contact Name |
|
| Email |
|
Add to My Favorite
Refer it to Friend
Report Broken Link
|
|
Other links at Biotechnology and Pharmaceuticals > Pharmaceuticals > Biopharmaceuticals > Research and Development |
| 1. |
Novacta Biosystems Ltd.
|
|
|
Drug discovery and development company using pathway engineering and chemistry to optimise the activity of natural products for the treatment of infectious diseases. Introduces biotransformation technology, lead compounds, key personnel in Hatfield, England.
|
| 2. |
AVI Biopharma, Inc.
|
|
|
Develops and commercializes a vaccine against human chorionic gonadotropin secreting cancers, and synthetic antisense technology to inhibit translation in treating cardiovascular, kidney and viral diseases. Research and manufacturing facilities in Corvallis, Oregon. (Nasdaq: AVII)
|
| 3. |
Praecis Pharmaceuticals Inc.
|
|
|
Develops peptide-based therapeutics for the treatment of human hormone diseases, prostate cancer endometriosis, and inflammatory diseases. Includes therapeutic targets and profile of facilities in Waltham, Massachusetts. (Nasdaq: PRCS)
|
| 4. |
Aphton Corp.
|
|
|
Develops products using vaccine-like technology for neutralizing hormones which participate in gastrointestinal system and reproductive system cancer and non-cancer diseases and the prevention of pregnancy. Based in Miami, Florida. (Nasdaq: APHT)
|
| 5. |
Genfit
|
|
|
Researching nuclear receptors and gene deregulation for treatment of cardiovascular, metabolic and inflammatory diseases. Includes information about genomic research headquartered in Loos, France.
|
|
|
